{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T18:01:05Z","timestamp":1792000865058,"version":"4.4.0"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:00:00Z","timestamp":1777507200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["330902"],"award-info":[{"award-number":["330902"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["374291"],"award-info":[{"award-number":["374291"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["337530"],"award-info":[{"award-number":["337530"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["357910"],"award-info":[{"award-number":["357910"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["358823"],"award-info":[{"award-number":["358823"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Suomen MS-S\u00e4\u00e4ti\u00f6"},{"DOI":"10.13039\/100008723","name":"Suomen L\u00e4\u00e4ketieteen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018696","name":"HORIZON EUROPE Health","doi-asserted-by":"publisher","award":["101057553"],"award-info":[{"award-number":["101057553"]}],"id":[{"id":"10.13039\/100018696","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005609","name":"University of Turku","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100005609","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A subset of individuals experience prolonged neurological and psychiatric symptoms following SARS-CoV-2 infection, a condition referred to as long COVID (LC). Limited evidence implicates ongoing neuroinflammatory processes as a driver of LC. This study investigates neuroinflammation in LC using translocator protein positron emission tomography (TSPO PET).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      14 LC, 11 healthy control (HC) and 13 multiple sclerosis (MS) participants were included in the study. They underwent [\n                      <jats:sup>11<\/jats:sup>\n                      C]PK11195 TSPO PET and 3T magnetic resonance imaging (MRI) to evaluate glial activation, white matter (WM) pathology and brain volumetrics. Serum neurofilament light chain (NfL) and glial fibrillary acidic protein (GFAP) were measured as markers of neuronal and glial damage. LC participants completed neurological examinations and mental health assessments.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      TSPO availability, measured as distribution volume ratio (DVR), was not elevated in LC compared to HCs but was significantly lower in LC compared to MS (WM DVR 1.03 vs. 1.06;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.007). Individuals imaged within 16\u00a0months of SARS-CoV-2 infection showed higher WM DVR compared to those with a longer disease duration (1.05 vs. 1.02;\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.04). Moreover, lower quality of life was associated with higher DVRs in the hippocampus, amygdala and thalamus (\u03c1\u2009= \u2212\u20090.83-\u2009\u2212\u20090.70), and depression and anxiety correlated positively with DVRs in the hippocampus and amygdala (\u03c1\u2009=\u20090.75\u20130.97).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>LC TSPO availability did not differ from HCs in any studied brain area. However, lower WM TSPO availability in individuals with longer LC duration suggests COVID-19-associated neuroinflammation may subside with time, while the association between limbic TSPO availability and LC severity may imply a role for limbic activity in LC symptomology.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s00415-026-13842-w","type":"journal-article","created":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T11:17:59Z","timestamp":1777547879000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Association between post-COVID-19 neuropsychiatric symptoms and persistent glial activation in the limbic system: a TSPO PET study"],"prefix":"10.1007","volume":"273","author":[{"given":"Joel","family":"Tuomaala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maija","family":"Saraste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilda","family":"Kuusi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabet","family":"Westerberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eveliina","family":"Honkonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahim","family":"Kargar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini","family":"Laaksonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jussi","family":"Lehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelie","family":"Luoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Matilainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olavi","family":"Misin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janne","family":"Atosuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Kanerva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Liira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sini","family":"Laakso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Posharina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virva","family":"Saunavaara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saara","family":"Wahlroos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Rajander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Airas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,30]]},"reference":[{"key":"13842_CR1","unstructured":"World Health Organization. A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021. document number: WHO\/2019-nCoV\/Post_COVID-19_condition\/Clinical_case_definition\/20211. Published Online First: 2021."},{"key":"13842_CR2","doi-asserted-by":"publisher","unstructured":"Davis HE, Assaf GS, McCorkell L, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. eClinicalMedicine. 2021;38:101019. https:\/\/doi.org\/10.1016\/j.eclinm.2021.101019","DOI":"10.1016\/j.eclinm.2021.101019"},{"key":"13842_CR3","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41380-022-01614-7","volume":"28","author":"N Zeng","year":"2023","unstructured":"Zeng N, Zhao Y-M, Yan W et al (2023) A systematic review and meta-analysis of long term physical and mental sequelae of COVID-19 pandemic: call for research priority and action. Mol Psychiatry 28:423\u2013433. https:\/\/doi.org\/10.1038\/s41380-022-01614-7","journal-title":"Mol Psychiatry"},{"key":"13842_CR4","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1038\/s41577-023-00904-7","volume":"23","author":"DM Altmann","year":"2023","unstructured":"Altmann DM, Whettlock EM, Liu S et al (2023) The immunology of long COVID. Nat Rev Immunol 23:618\u2013634. https:\/\/doi.org\/10.1038\/s41577-023-00904-7","journal-title":"Nat Rev Immunol"},{"key":"13842_CR5","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1038\/d41586-024-00828-9","volume":"628","author":"LC L\u00f3pez","year":"2024","unstructured":"L\u00f3pez LC (2024) COVID\u2019s toll on the brain: new clues emerge. Nature 628:20\u201320. https:\/\/doi.org\/10.1038\/d41586-024-00828-9","journal-title":"Nature"},{"key":"13842_CR6","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1016\/j.neuron.2022.10.006","volume":"110","author":"M Monje","year":"2022","unstructured":"Monje M, Iwasaki A (2022) The neurobiology of long COVID. Neuron 110:3484\u20133496. https:\/\/doi.org\/10.1016\/j.neuron.2022.10.006","journal-title":"Neuron"},{"key":"13842_CR7","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/s41579-022-00846-2","volume":"21","author":"HE Davis","year":"2023","unstructured":"Davis HE, McCorkell L, Vogel JM et al (2023) Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol 21:133\u2013146. https:\/\/doi.org\/10.1038\/s41579-022-00846-2","journal-title":"Nat Rev Microbiol"},{"key":"13842_CR8","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1042\/BST20150058","volume":"43","author":"FE Turkheimer","year":"2015","unstructured":"Turkheimer FE, Rizzo G, Bloomfield PS et al (2015) The methodology of TSPO imaging with positron emission tomography. Biochem Soc Trans 43:586\u2013592. https:\/\/doi.org\/10.1042\/BST20150058","journal-title":"Biochem Soc Trans"},{"key":"13842_CR9","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1016\/j.bbi.2024.04.015","volume":"119","author":"MB VanElzakker","year":"2024","unstructured":"VanElzakker MB, Bues HF, Brusaferri L et al (2024) Neuroinflammation in post-acute sequelae of COVID-19 (PASC) as assessed by [11C]PBR28 PET correlates with vascular disease measures. Brain Behav Immun 119:713\u2013723. https:\/\/doi.org\/10.1016\/j.bbi.2024.04.015","journal-title":"Brain Behav Immun"},{"key":"13842_CR10","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1001\/jamapsychiatry.2023.1321","volume":"80","author":"J Braga","year":"2023","unstructured":"Braga J, Lepra M, Kish SJ et al (2023) Neuroinflammation After COVID-19 With Persistent Depressive and Cognitive Symptoms. JAMA Psychiat 80:787\u2013795. https:\/\/doi.org\/10.1001\/jamapsychiatry.2023.1321","journal-title":"JAMA Psychiat"},{"key":"13842_CR11","doi-asserted-by":"publisher","unstructured":"Filippo MD, Gaetani L, Centonze D, et al. Fluid biomarkers in multiple sclerosis: from current to future applications. The Lancet Regional Health \u2013 Europe. 2024; https:\/\/doi.org\/10.1016\/j.lanepe.2024.101009","DOI":"10.1016\/j.lanepe.2024.101009"},{"key":"13842_CR12","doi-asserted-by":"publisher","first-page":"e3019","DOI":"10.1093\/cid\/ciaa1933","volume":"73","author":"A Pilotto","year":"2021","unstructured":"Pilotto A, Masciocchi S, Volonghi I et al (2021) Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Encephalitis Is a Cytokine Release Syndrome: Evidences From Cerebrospinal Fluid Analyses. Clin Infect Dis 73:e3019\u2013e3026. https:\/\/doi.org\/10.1093\/cid\/ciaa1933","journal-title":"Clin Infect Dis"},{"key":"13842_CR13","doi-asserted-by":"publisher","first-page":"2270","DOI":"10.3390\/cells12182270","volume":"12","author":"MA Zingaropoli","year":"2023","unstructured":"Zingaropoli MA, Pasculli P, Barbato C et al (2023) Biomarkers of Neurological Damage: From Acute Stage to Post-Acute Sequelae of COVID-19. Cells 12:2270. https:\/\/doi.org\/10.3390\/cells12182270","journal-title":"Cells"},{"key":"13842_CR14","doi-asserted-by":"publisher","unstructured":"Kanberg N, Simr\u00e9n J, Ed\u00e9n A, et al. Neurochemical signs of astrocytic and neuronal injury in acute COVID-19 normalizes during long-term follow-up. eBioMedicine. 2021;70:103512. https:\/\/doi.org\/10.1016\/j.ebiom.2021.103512","DOI":"10.1016\/j.ebiom.2021.103512"},{"key":"13842_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24032715","volume":"24","author":"MP Lennol","year":"2023","unstructured":"Lennol MP, Ashton NJ, Moreno-P\u00e9rez O et al (2023) Transient changes in the plasma of astrocytic and neuronal injury biomarkers in COVID-19 patients without neurological syndromes. Int J Mol Sci 24:2715. https:\/\/doi.org\/10.3390\/ijms24032715","journal-title":"Int J Mol Sci"},{"key":"13842_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jpm14030313","volume":"14","author":"CS Vrettou","year":"2024","unstructured":"Vrettou CS, Vassiliou AG, Keskinidou C et al (2024) A prospective study on neural biomarkers in patients with long-COVID symptoms. J Pers Med 14:313. https:\/\/doi.org\/10.3390\/jpm14030313","journal-title":"J Pers Med"},{"key":"13842_CR17","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000200003","volume":"9","author":"MJ Peluso","year":"2022","unstructured":"Peluso MJ, Sans HM, Forman CA et al (2022) Plasma markers of neurologic injury and inflammation in people with self-reported neurologic postacute sequelae of SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm 9:e200003. https:\/\/doi.org\/10.1212\/NXI.0000000000200003","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13842_CR18","volume-title":"EUROHIS: Developing common instruments for health surveys","author":"A Nosikov","year":"2003","unstructured":"Nosikov A, Gudex C (2003) EUROHIS: Developing common instruments for health surveys. Published on behalf of the World Health Organization Regional Office for Europe by IOS Press\u202f; Ohmsha, Amsterdam, Washington, D.C."},{"key":"13842_CR19","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3109\/07853890109002089","volume":"33","author":"RD Hays","year":"2001","unstructured":"Hays RD, Morales LS (2001) The RAND-36 measure of health-related quality of life. Ann Med 33:350\u2013357. https:\/\/doi.org\/10.3109\/07853890109002089","journal-title":"Ann Med"},{"key":"13842_CR20","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB, LaRocca NG, Muir-Nash J (1989) The fatigue severity scale: application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46:1121\u20131123. https:\/\/doi.org\/10.1001\/archneur.1989.00520460115022","journal-title":"Arch Neurol"},{"key":"13842_CR21","doi-asserted-by":"publisher","first-page":"S79","DOI":"10.1093\/clinids\/18.Supplement_1.S79","volume":"18","author":"JD Fisk","year":"1994","unstructured":"Fisk JD, Ritvo PG, Ross L et al (1994) Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis 18:S79-83. https:\/\/doi.org\/10.1093\/clinids\/18.Supplement_1.S79","journal-title":"Clin Infect Dis"},{"key":"13842_CR22","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW et al (2006) A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med 166:1092\u20131097. https:\/\/doi.org\/10.1001\/archinte.166.10.1092","journal-title":"Arch Intern Med"},{"key":"13842_CR23","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW (2001) The PHQ-9. J Gen Intern Med 16:606\u2013613. https:\/\/doi.org\/10.1046\/j.1525-1497.2001.016009606.x","journal-title":"J Gen Intern Med"},{"key":"13842_CR24","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1093\/sleep\/34.5.601","volume":"34","author":"CM Morin","year":"2011","unstructured":"Morin CM, Belleville G, B\u00e9langer L et al (2011) The insomnia severity index: psychometric indicators to detect insomnia cases and evaluate treatment response. Sleep 34:601\u2013608. https:\/\/doi.org\/10.1093\/sleep\/34.5.601","journal-title":"Sleep"},{"key":"13842_CR25","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1002\/mpr.61","volume":"8","author":"J Rehm","year":"1999","unstructured":"Rehm J, \u00dcst\u00fcn TB, Saxena S et al (1999) On the development and psychometric testing of the WHO screening instrument to assess disablement in the general population. Int J Methods Psychiatr Res 8:110\u2013122. https:\/\/doi.org\/10.1002\/mpr.61","journal-title":"Int J Methods Psychiatr Res"},{"key":"13842_CR26","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1136\/jnnp-2023-331051","volume":"94","author":"M Saraste","year":"2023","unstructured":"Saraste M, Matilainen M, Vuorimaa A et al (2023) Association of serum neurofilament light with microglial activation in multiple sclerosis. J Neurol Neurosurg Psychiatry 94:698\u2013706. https:\/\/doi.org\/10.1136\/jnnp-2023-331051","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"13842_CR27","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000000443","volume":"5","author":"E Rissanen","year":"2018","unstructured":"Rissanen E, Tuisku J, Vahlberg T et al (2018) Microglial activation, white matter tract damage, and disability in MS. Neurol Neuroimmunol Neuroinflamm 5:e443. https:\/\/doi.org\/10.1212\/NXI.0000000000000443","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13842_CR28","first-page":"158","volume":"48","author":"FE Turkheimer","year":"2007","unstructured":"Turkheimer FE, Edison P, Pavese N et al (2007) Reference and Target Region Modeling of [11C]-(R)-PK11195 Brain Studies. J Nucl Med 48:158\u2013167","journal-title":"J Nucl Med"},{"key":"13842_CR29","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1038\/jcbfm.2012.59","volume":"32","author":"M Yaqub","year":"2012","unstructured":"Yaqub M, van Berckel BN, Schuitemaker A et al (2012) Optimization of supervised cluster analysis for extracting reference tissue input curves in (R)-[11C]PK11195 brain PET studies. J Cereb Blood Flow Metab 32:1600\u20131608. https:\/\/doi.org\/10.1038\/jcbfm.2012.59","journal-title":"J Cereb Blood Flow Metab"},{"key":"13842_CR30","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001182","volume":"9","author":"O Misin","year":"2022","unstructured":"Misin O, Matilainen M, Nylund M et al (2022) Innate immune cell\u2013related pathology in the thalamus signals a risk for disability progression in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 9:e1182. https:\/\/doi.org\/10.1212\/NXI.0000000000001182","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"key":"13842_CR31","doi-asserted-by":"publisher","unstructured":"Nylund M, Sucksdorff M, Matilainen M, et al. Phenotyping of multiple sclerosis lesions according to innate immune cell activation using 18 kDa translocator protein-PET. Brain Commun. 2021;4:fcab301. https:\/\/doi.org\/10.1093\/braincomms\/fcab301","DOI":"10.1093\/braincomms\/fcab301"},{"key":"13842_CR32","doi-asserted-by":"publisher","unstructured":"Cheung G, Lin YC, Papadopoulos V. Translocator protein in the rise and fall of central nervous system neurons. Front Cell Neurosci. 2023;. https:\/\/doi.org\/10.3389\/fncel.2023.1210205","DOI":"10.3389\/fncel.2023.1210205"},{"key":"13842_CR33","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.1038\/s41380-020-0745-1","volume":"26","author":"T Notter","year":"2021","unstructured":"Notter T, Schalbetter SM, Clifton NE et al (2021) Neuronal activity increases translocator protein (TSPO) levels. Mol Psychiatry 26:2025\u20132037. https:\/\/doi.org\/10.1038\/s41380-020-0745-1","journal-title":"Mol Psychiatry"},{"key":"13842_CR34","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1111\/bpa.12198","volume":"24","author":"ML Estes","year":"2014","unstructured":"Estes ML, McAllister AK (2014) Alterations in immune cells and mediators in the brain: it\u2019s not always neuroinflammation! Brain Pathol 24:623\u2013630. https:\/\/doi.org\/10.1111\/bpa.12198","journal-title":"Brain Pathol"},{"key":"13842_CR35","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1126\/science.aat0473","volume":"362","author":"NJ Allen","year":"2018","unstructured":"Allen NJ, Lyons DA (2018) Glia as architects of central nervous system formation and function. Science 362:181\u2013185. https:\/\/doi.org\/10.1126\/science.aat0473","journal-title":"Science"},{"key":"13842_CR36","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2023.1187163","volume":"10","author":"AL Komaroff","year":"2023","unstructured":"Komaroff AL, Lipkin WI (2023) ME\/CFS and long COVID share similar symptoms and biological abnormalities: road map to the literature. Front Med 10:1187163. https:\/\/doi.org\/10.3389\/fmed.2023.1187163","journal-title":"Front Med"},{"key":"13842_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2022.877772","volume":"13","author":"W Tate","year":"2022","unstructured":"Tate W, Walker M, Sweetman E et al (2022) Molecular mechanisms of neuroinflammation in ME\/CFS and long COVID to sustain disease and promote relapses. Front Neurol 13:877772. https:\/\/doi.org\/10.3389\/fneur.2022.877772","journal-title":"Front Neurol"},{"key":"13842_CR38","doi-asserted-by":"publisher","first-page":"945","DOI":"10.2967\/jnumed.113.131045","volume":"55","author":"Y Nakatomi","year":"2014","unstructured":"Nakatomi Y, Mizuno K, Ishii A et al (2014) Neuroinflammation in patients with Chronic Fatigue Syndrome\/Myalgic Encephalomyelitis: an 11C-(R)-PK11195 PET study. J Nucl Med 55:945\u2013950. https:\/\/doi.org\/10.2967\/jnumed.113.131045","journal-title":"J Nucl Med"},{"key":"13842_CR39","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bbi.2019.06.015","volume":"81","author":"D Enache","year":"2019","unstructured":"Enache D, Pariante CM, Mondelli V (2019) Markers of central inflammation in major depressive disorder: a systematic review and meta-analysis of studies examining cerebrospinal fluid, positron emission tomography and post-mortem brain tissue. Brain Behav Immun 81:24\u201340. https:\/\/doi.org\/10.1016\/j.bbi.2019.06.015","journal-title":"Brain Behav Immun"},{"key":"13842_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2022.981442","author":"B Eggerstorfer","year":"2022","unstructured":"Eggerstorfer B, Kim J-H, Cumming P et al (2022) Meta-analysis of molecular imaging of translocator protein in major depression. Front Mol Neurosci. https:\/\/doi.org\/10.3389\/fnmol.2022.981442","journal-title":"Front Mol Neurosci."},{"key":"13842_CR41","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2967\/jnumed.124.269297","volume":"66","author":"D Visser","year":"2025","unstructured":"Visser D, Golla SSV, Palard-Novello X et al (2025) Varying levels of inflammatory activity in brain and body of patients with persistent fatigue and difficulty concentrating after COVID-19: a TSPO PET study. J Nucl Med 66:1787\u20131794. https:\/\/doi.org\/10.2967\/jnumed.124.269297","journal-title":"J Nucl Med"},{"key":"13842_CR42","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s00259-021-05425-w","volume":"49","author":"F Chauveau","year":"2021","unstructured":"Chauveau F, Becker G, Boutin H (2021) Have (R)-[11C]PK11195 challengers fulfilled the promise? A scoping review of clinical TSPO PET studies. Eur J Nucl Med Mol Imaging 49:201\u2013220. https:\/\/doi.org\/10.1007\/s00259-021-05425-w","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"13842_CR43","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.apsb.2020.08.006","volume":"11","author":"L Zhang","year":"2021","unstructured":"Zhang L, Hu K, Shao T et al (2021) Recent developments on PET radiotracers for TSPO and their applications in neuroimaging. Acta Pharm Sin B 11:373\u2013393. https:\/\/doi.org\/10.1016\/j.apsb.2020.08.006","journal-title":"Acta Pharm Sin B"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13842-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-026-13842-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-026-13842-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T10:43:47Z","timestamp":1779446627000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-026-13842-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,30]]},"references-count":43,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["13842"],"URL":"https:\/\/doi.org\/10.1007\/s00415-026-13842-w","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,30]]},"assertion":[{"value":"18 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"This study involves human participants and was approved by the Ethics Committee of the Hospital District of Southwest Finland (reference numbers 56\/1801\/2021, 89\/1800\/2019 and 67\/1801\/2018). All study participants have provided written informed consent that covers the use of their data in this study. All procedures performed were in line with the principles of the 1964 Declaration of Helsinki and its later amendments.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}}],"article-number":"298"}}